Xience DES

everolimus-eluting stent · Abbott Vascular

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Xience DES, covering 2017-10-19 to 2017-10-19. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Response to Vascular Injury in Patients With Diabetes Mellitus: An OCT Study of BVS Versus Xience DES [NA]

See pricing